Clinical Laserthermia Systems AB (publ) (CLS) announced that Rolf Ho Bornschein has been appointed as the new CFO for CLS. The current CFO, Lars-Erik Eriksson, will leave his present position. However, Lars-Erik, who is one of the co-founders of CLS, retains a central role in the company as a member of the Board.

Rolf Ho Bornschein has extensive international experience from senior positions in both the finance and MedTech sectors, including as a CFO. His most recent role was as Director Tracheostomy and 3PP ENT Sales at Atos Medical AB, which is owned by the Danish MedTech company Coloplast. In the role of CFO, Rolf will also be part of the CLS Executive Management Team.

He commences his role on 1 October.